FT819 in Subjects With B-cell Malignancies
Fate Therapeutics
Fate Therapeutics
Syndax Pharmaceuticals
AvenCell Therapeutics, Inc.
Incyte Corporation
Dren Bio
Allogene Therapeutics
BeOne Medicines
Ossium Health, Inc.
Ossium Health, Inc.
Vironexis Biotherapeutics Inc.
GeoVax, Inc.
Incyte Corporation
Pfizer
Adela, Inc
AstraZeneca
Acerta Pharma BV
AbbVie
First Ascent Biomedical Inc.
Incyte Corporation
AbbVie
Kura Oncology, Inc.
AVM Biotechnology Inc
Massive Bio, Inc.
CRISPR Therapeutics
Incyte Corporation
Biotroy Therapeutics
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
CRISPR Therapeutics
Cogent Biosciences, Inc.
Amgen
Tempus AI
Genmab
Ono Pharmaceutical Co. Ltd
Zhejiang DTRM Biopharma
Acerta Pharma BV
Pharmacyclics LLC.
Munich Leukemia Laboratory
Takara Bio Inc.
Vincerx Pharma, Inc.
Xencor, Inc.
BeiGene
Servier
Cyclacel Pharmaceuticals, Inc.
Pfizer
OrphAI Therapeutics
Celgene
Syndax Pharmaceuticals
Kyowa Kirin Co., Ltd.
Amgen
Pack Health